Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
E3 ubiquitin-protein ligase CCNB1IP1 (CCNB1IP1) is a member of the E3 ubiquitin ligase family that plays a critical role in cell cycle progression, particularly the regulation of G2/M transition, and is required for the proper formation of crossovers during meiosis[1][2][6]. It functions by mediating ubiquitin-dependent protein modification, thereby marking specific substrates for degradation or regulatory modification. During meiosis, CCNB1IP1 helps ensure accurate chromosome segregation by promoting the formation of crossover sites, interacting with other proteins involved in homologous recombination and DNA repair[1][2][6]. Overexpression of CCNB1IP1 can disrupt the timing of mitosis, illustrating its essential role in cell cycle control[1]. Alterations in its expression or function have been associated with certain cancers, such as Schwannomatosis, and potentially other diseases where cell cycle dysregulation plays a part[1][2].
Modulation of protein stability through ubiquitin-mediated proteasomal degradation Limiting factor for chromosomal crossover during meiosis by regulating protein-protein interactions at recombination sites
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on E3 ubiquitin-protein ligase CCNB1IP1 (CCNB1IP1).